TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $33,000 | +32.0% | 3,000 | -33.3% | 0.00% | +50.0% |
| Q3 2019 | $25,000 | -28.6% | 4,500 | +12.5% | 0.00% | -50.0% |
| Q2 2019 | $35,000 | +2.9% | 4,000 | -5.9% | 0.00% | 0.0% |
| Q1 2019 | $34,000 | +161.5% | 4,250 | +30.8% | 0.00% | +100.0% |
| Q4 2018 | $13,000 | -43.5% | 3,250 | -20.2% | 0.00% | -33.3% |
| Q3 2018 | $23,000 | +475.0% | 4,075 | +1258.3% | 0.00% | +200.0% |
| Q2 2018 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |